a Pediatric Infectious Diseases and Immunodeficiencies Unit , Hospital Universitari Vall d'Hebron , Barcelona , Spain.
b Translational Pediatrics and Infectious Diseases, Department of Pediatrics , Complejo Hospitalario Universitario de Santiago de Compostela , Santiago de Compostela , Spain.
Expert Rev Anti Infect Ther. 2018 Mar;16(3):243-254. doi: 10.1080/14787210.2018.1438265. Epub 2018 Feb 15.
Zika virus (ZIKV) infection has caused the most challenging worldwide infectious epidemic outbreak in recent months. ZIKV causes microcephaly and other congenital malformations. There is a need to perform updated systematic reviews on ZIKV infection periodically because this epidemic is bringing up new evidence with extraordinary speed. Areas covered: Evidence related to ZIKV infection in the gestational, perinatal, and early infant periods covering epidemiology, virology, pathogenesis, risk factors, time of infection during pregnancy, newborn symptoms, treatment, and vaccines. To this end, a search was performed using terms ['Zika'] AND ['Perinatal Infection'] OR ['Congenital Infection'] in the PubMed® international electronic database. Out of a total of 1,538 articles published until 30 November 2017, we finally assessed 106 articles articles that were relevant to the research areas included in this study. Expert commentary: ZIKV is a new teratogenic/neurotropic virus affecting fetuses. Many challenges are still far from being solved regarding the epidemiology, case definition, clinical and laboratory diagnosis, and preventive measures. An approach using 'omics' and new biomarkers for diagnosis, and a ZIKV-vaccine for treatment, might finally give us the tools to solve these challenges.
寨卡病毒(ZIKV)感染已导致最近数月来全球范围内最具挑战性的传染病爆发。ZIKV 可导致小头畸形和其他先天畸形。由于这种传染病以非凡的速度不断提出新的证据,因此有必要定期对 ZIKV 感染进行更新的系统评价。涵盖领域:涵盖围产期和婴儿早期 ZIKV 感染的流行病学、病毒学、发病机制、危险因素、妊娠期间感染时间、新生儿症状、治疗和疫苗等方面的证据。为此,在国际电子数据库 PubMed®中使用术语 ['Zika'] 和 ['围产期感染'] 或 ['先天性感染'] 进行了搜索。在截至 2017 年 11 月 30 日发表的总共 1538 篇文章中,我们最终评估了与本研究领域相关的 106 篇文章。专家评论:ZIKV 是一种新的致畸/神经毒性病毒,可影响胎儿。在流行病学、病例定义、临床和实验室诊断以及预防措施方面,仍有许多挑战远未得到解决。使用“组学”和新的诊断生物标志物以及 ZIKV 疫苗进行治疗的方法,最终可能为我们提供解决这些挑战的工具。